200 related articles for article (PubMed ID: 12769749)
21. Cytokine networks--towards new therapies for rheumatoid arthritis.
McInnes IB; Liew FY
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
[TBL] [Abstract][Full Text] [Related]
22. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
[TBL] [Abstract][Full Text] [Related]
23. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
Reumatizam; 2008; 55(1):22-5. PubMed ID: 19024266
[TBL] [Abstract][Full Text] [Related]
24. Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis.
Kary S; Burmester GR
Int J Clin Pract; 2003 Apr; 57(3):231-4. PubMed ID: 12723729
[TBL] [Abstract][Full Text] [Related]
25. Antibody therapy for rheumatoid arthritis.
Taylor PC
Curr Opin Pharmacol; 2003 Jun; 3(3):323-8. PubMed ID: 12810200
[TBL] [Abstract][Full Text] [Related]
26. [Rheumatoid arthritis: current status of therapy].
El Bahri DM; Meddeb N; Sellami S
Tunis Med; 2007 Jan; 85(1):1-8. PubMed ID: 17424701
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapy in rheumatoid arthritis.
Köller MD
Wien Med Wochenschr; 2006 Jan; 156(1-2):53-60. PubMed ID: 16465614
[TBL] [Abstract][Full Text] [Related]
28. Biological agents for rheumatoid arthritis: targeting both physical function and structural damage.
Klinkhoff A
Drugs; 2004; 64(12):1267-83. PubMed ID: 15200343
[TBL] [Abstract][Full Text] [Related]
29. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
30. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
31. TNF alpha as a therapeutic target in rheumatoid arthritis.
Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
[TBL] [Abstract][Full Text] [Related]
32. Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis.
Baldwin HM; Ito-Ihara T; Isaacs JD; Hilkens CM
Ann Rheum Dis; 2010 Jun; 69(6):1200-7. PubMed ID: 19773288
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 in rheumatoid arthritis.
Nishimoto N
Curr Opin Rheumatol; 2006 May; 18(3):277-81. PubMed ID: 16582692
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of rheumatoid arthritis: targeting cytokines.
Zwerina J; Redlich K; Schett G; Smolen JS
Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
[TBL] [Abstract][Full Text] [Related]
35. Cytokine blockade in rheumatoid arthritis.
Feldmann M; Maini RN; Bondeson J; Taylor P; Foxwell BM; Brennan FM
Adv Exp Med Biol; 2001; 490():119-27. PubMed ID: 11505970
[TBL] [Abstract][Full Text] [Related]
36. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y
Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
[TBL] [Abstract][Full Text] [Related]
37. Targeting rheumatoid tenosynovial angiogenesis with cytokine inhibitors.
Jain A; Kiriakidis S; Brennan F; Sandison A; Paleolog E; Nanchahal J
Clin Orthop Relat Res; 2006 May; 446():268-77. PubMed ID: 16456308
[TBL] [Abstract][Full Text] [Related]
38. Biological agents in rheumatoid arthritis.
Shankar S; Handa R
J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis and therapy of rheumatoid arthritis.
Williams RO
Ernst Schering Found Symp Proc; 2006; (1):107-30. PubMed ID: 17824174
[TBL] [Abstract][Full Text] [Related]
40. Biologics in Inflammatory and Immunomediated Arthritis.
Luchetti MM; Benfaremo D; Gabrielli A
Curr Pharm Biotechnol; 2017; 18(12):989-1007. PubMed ID: 29278210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
